Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates
Science · 09.08.2024 · 385 (6709)
DOI: 10.1126/science.adn5866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 09.08.2024. Verfasst von Fathima N Nagoor Pitchai und 27 weiteren Autor:innen. Beteiligte Einrichtung: Gladstone Center for Cell Circuitry, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Virus Replication, Viral Interference. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Antiviral therapies with reduced frequencies of administration and high barriers to resistance remain a major goal. For HIV, theories have proposed that viral-deletion variants, which conditionally replicate with a basic reproductive ratio [R 0 ] > 1 (termed “therapeutic interfering particles” or “TIPs”), could parasitize wild-type virus to constitute single-administration, escape-resistant antiviral therapies. We report the engineering of a TIP that, in rhesus macaques, reduces viremia of a highly pathogenic model of HIV by >3log 10 following a single intravenous injection. Animal lifespan was significantly extended, TIPs conditionally replicated and were continually detected for >6 months, and sequencing data showed no evidence of viral escape. A single TIP injection also suppressed virus replication in humanized mice and cells from persons living with HIV. These data provide proof of concept for a potential new class of single-administration antiviral therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Gladstone Center for Cell Circuitry, University of California, San Francisco, CA, USA.
- Gladstone Institute of Virology, University of California, San Francisco, CA, USA.
- Department of Bioengineering, University of Washington, Seattle, WA, USA.
- Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
- Absci Corporation, Vancouver, WA, USA.
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Förderung
- NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NIDA NIH HHS
- NCRR NIH HHS
Zitieren
APA
Pitchai, F. N. N., Tanner, E. J., Khetan, N., Vasen, G., Levrel, C., Kumar, A. J., Pandey, S., Ordonez, T., Barnette, P., Spencer, D., Jung, S. Y., Glazier, J., Thompson, C., Harvey-Vera, A., Son, H. I., Son, H. I., Strathdee, S. A., Holguin, L., Urak, R., …, & Weinberger, L. S. (2024). Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates. Science, 385(6709). https://doi.org/10.1126/science.adn5866
Vancouver
Pitchai FNN, Tanner EJ, Khetan N, Vasen G, Levrel C, Kumar AJ, et al. Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates. Science. 2024;385(6709). doi:10.1126/science.adn5866
BibTeX
@article{Pitchai2024,
author = {Pitchai, Fathima N Nagoor and Tanner, Elizabeth J and Khetan, Neha and Vasen, Gustavo and Levrel, Clara and Kumar, Arjun J and Pandey, Shilpi and Ordonez, Tracy and Barnette, Philip and Spencer, David and Jung, Seung-Yong and Glazier, Joshua and Thompson, Cassandra and Harvey-Vera, Alicia and Son, Hye-In and Son, Hye-In and Strathdee, Steffanie A and Holguin, Leo and Urak, Ryan and Burnett, John and Burgess, William and Busman-Sahay, Kathleen and Estes, Jacob D and Hessell, Ann and Fennessey, Christine M and Keele, Brandon F and Haigwood, Nancy L and Weinberger, Leor S},
title = {Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates},
journal = {Science},
year = {2024},
volume = {385},
number = {6709},
doi = {10.1126/science.adn5866}
}
EUVIMED